Results 301 to 310 of about 2,657,261 (342)

In vitro evidence to support amphotericin B and flucytosine combination therapy for talaromycosis. [PDF]

PLoS Negl Trop Dis
Natesan Sambath H, Vitsupakorn S, Sreerama Reddy K, Brown L, Nguyen TTM, Burke M, Liu J, Evans E, Giamberardino C, Perfect J, Hoa NT, Le T.   +11 more
europepmc   +1 more source

Synergistic effects of vedolizumab and JAK 1,2,3 inhibitors in Crohn's disease: insights from a systems biology and artificial intelligence-based approach. [PDF]

Front Immunol
Marín-Jiménez I, Sierra-Ausín M, Letosa-Abián T, Aparicio J, Montoto-Otero C, Sánchez-Ramón S.   +5 more
europepmc   +1 more source

Pharmacovigilance Insights Into Immune Checkpoint Inhibitor-Induced Risk of Paraneoplastic Syndrome: A Large-Scale Real World Study. [PDF]

CNS Neurosci Ther
Tang B, Song X, Sun Y, Wan J, Hu W, Ma Y, Lin Y, Zhang J, Wang Y, Feng H, Luo P, Guo D, Qu X.   +12 more
europepmc   +1 more source

Advancing Epigenetic Combination Therapy in Oncology: Multifunctional Nano-Drug Delivery Systems for Synergistic Efficacy and Precision Modulation. [PDF]

Int J Nanomedicine
Gao T, Fu S, Quan X, Sun J, Jiang M, Li J.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Recent advances in nanotechnology based combination drug therapy for skin cancer

Journal of Biomaterials Science. Polymer Edition, 2022
Skin-cancer (SC) is more common than all other cancers affecting large percentage of the population in the world and is increasing in terms of morbidity and mortality.
S. Kumari, P. Choudhary, R. Shukla, A. Sahebkar, Prashant Kesharwani   +4 more
semanticscholar   +1 more source

ROS‐Responsive Camptothecin Prodrug Nanoparticles for On‐Demand Drug Release and Combination of Chemotherapy and Photodynamic Therapy

Advanced Functional Materials, 2020
Minimizing drug leakage in systemic circulation, synchronizing the in vivo fate of multiple drugs, and precisely controlling tumor locoregional drug release, remain challenging for nanomedicine‐based cancer therapy.
Bingyang Chu, Y. Qu, Xinlong He, Ying Hao, Chengli Yang, Yun Yang, D. Hu, Fangfang Wang, Z. Qian   +8 more
semanticscholar   +1 more source